Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark,...
HEALTH & FITNESS
Ben Sasse shines spotlight on daraxonrasib for pancreatic cancer
Revolution Medicines could be on the cusp of a breakthrough. The company expects to soon release results from a Phase 3...
European pharma jeopardized by Trump policies, China’s biotech boom
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on...
Mom tech entrepreneur creating agentic AI for rare-disease families
Citizen Health CEO and Co-founder Farid Vij, and Citizen Health Chief Business Officer and Co-founder Nasha Fitter.Citizen HealthA version of...
Pancreatic cancer drug daraxonrasib from Revolution Medicines succeeds in trial
Pancreatic cancer, illustrationNemes Laszl | Science Photo Library | Getty ImagesRevolution Medicines' drug for pancreatic cancer succeeded in a highly...
Raising son with Angelman changed me as doctor and father
Dr. Joseph D'Orazio and his son, Gabe.Joseph D'OrazioA version of this story first appeared in the CNBC Cures newsletter. Click...
FDA declines to issue specific guidance on drug importation by AFPs
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009.Jason Reed | ReutersThe Food...
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark...
Novo says Wegovy pill outperforms Lilly’s oral GLP-1
Wegovy semaglutide tablets.Michael Siluk | Universal Images Group | Getty ImagesThe Wegovy pill showed more pronounced weight loss and less...
Eli Lilly opposes Trump MFN drug pricing law, CEO Ricks says
Dave Ricks, CEO of Eli Lilly, speaks in the Oval Office during an event about weight loss drugs at the...
Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time...
Novo Nordisk launches Wegovy subscription for GLP-1 obesity drugs
Wegovy semaglutide tablets.Michael Siluk | Universal Images Group | Getty ImagesNovo Nordisk on Tuesday launched a multi-month subscription program for...
Eli Lilly reaches deal to bring AI-developed drugs to global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake...
AstraZeneca stock jumps after surprise lung disease trial win
AstraZeneca's stock jumped nearly 5% after Britain's most valuable company said its experimental lung disease medicine met its target in...
Danone to buy protein shake maker Huel as health nutrition craze drives demand shift
Huel makes vegan, powdered meal replacements, catering to people who "deem themselves time-poor" but want healthy, environmentally sustainable meals.Source: HuelFrench...
Restaurants add protein, fiber for weight loss drug users
A mini burger, mini fries and mini beer, Clinton Hall's "Teeny Weeny Mini Meal", is pictured next to a regular-sized...
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. She wanted my help building a platform at CNBC to...
ACA enrollees go uninsured after enhanced subsidies expire: KFF poll
Many Americans are feeling the financial pain following the expiration of enhanced federal subsidies for Affordable Care Act marketplace health...
FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,...
Stopping GLP-1s raises cardiovascular risks: study
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Hollie Adams | ReutersA version of this...
